On July 17, Stryker fell 3.09% in regular trading, trading at $321.89/share, with turnover of $246 million.

On the news front, the Health Care Equipment sector came under broad-based selling pressure, led by industry bellwether Intuitive Surgical which plunged over 11%, exerting significant drag across the group. GE Healthcare declined 2.21% and Boston Scientific fell 1.19%, with Stryker weakening in sympathy as a core sector constituent.

The sector selloff follows earlier weakness triggered by HCA Healthcare's disappointing outlook on July 14, which raised concerns about slowing healthcare demand. On that same day, Goldman Sachs cut its price target on Stryker to $339 from $363 while maintaining a Neutral rating. Stryker is scheduled to report second quarter earnings on July 30 after market close, with consensus expecting adjusted EPS of $3.46.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)